Authors: COONEY GF SELLERS P BROWNE B MANCANO M SALLAS WM HEIFETS M

Citation: Gf. Cooney et al., IMPROVED CORRELATION BETWEEN TROUGH CYCLOSPORINE LEVELS AND AUCS FOR NEW ORAL MICROEMULSION FORMULATION, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 104-104

Authors: SALLAS WM NEDELMAN JR SHEINER LB MELIGENI JA ROBINSON WT

Citation: Wm. Sallas et al., A NONLINEAR MIXED-EFFECTS PHARMACOKINETIC MODEL COMPARING 2 FORMULATIONS OF CYCLOSPORINE IN STABLE RENAL-TRANSPLANT PATIENTS, Journal of pharmacokinetics and biopharmaceutics, 23(5), 1995, pp. 495-514

Authors: SALLAS WM

Citation: Wm. Sallas, DEVELOPMENT OF LIMITED SAMPLING STRATEGIES FOR CHARACTERISTICS OF A PHARMACOKINETIC PROFILE, Journal of pharmacokinetics and biopharmaceutics, 23(5), 1995, pp. 515-529

Authors: SALLAS WM MELIGENI JA CHARNICK SB

Citation: Wm. Sallas et al., PK PD ANALYSIS FOR CYCLOSPORINE, MARKETED AND MICROEMULSION FORMULATIONS, IN PSORIASIS PATIENTS/, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 155-155

Authors: SALLAS WM SCHRAN HF

Citation: Wm. Sallas et Hf. Schran, LINEAR MIXED EFFECTS MODELS FOR TROUGH CONCENTRATIONS OF CYCLOSPORINE-A AND CYCLOSPORINE-G, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 162-162